{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/bf0792d1-9ff8-5db0-8a06-13bcd189b631/346abd01-7bf3-4dc4-b05e-9fdf3117c756?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Early career investigator highlight: Dr. Adam Frymoyer","description":"This is the first in a series of bi-monthly episodes centered around an Early Career Investigator who publishes in the journal. This month, we meet Dr. Adam Frymoyer, a clinical assistant professor in the department of pediatrics at Stanford University.  He describes himself as a 39 year old physician-scientist, passionate about promoting the safe and efficacious use of therapeutic drugs in neonates and children. He has established a cross-disciplinary research program that focuses on the application of clinical pharmacokinetics and pharmacodynamics to guide therapeutic decision making in children.<img src=\"http://feeds.feedburner.com/~r/prpodcast/podcast/current/~4/Lntto_gjKSE\" height=\"1\" width=\"1\" alt=\"\"/>","author_name":"Nature Publishing Group"}